HU196307B - Process for producing vermicides comprising levamisole-nitroxinil salt - Google Patents

Process for producing vermicides comprising levamisole-nitroxinil salt Download PDF

Info

Publication number
HU196307B
HU196307B HU844307A HU430784A HU196307B HU 196307 B HU196307 B HU 196307B HU 844307 A HU844307 A HU 844307A HU 430784 A HU430784 A HU 430784A HU 196307 B HU196307 B HU 196307B
Authority
HU
Hungary
Prior art keywords
salt
levamisole
glucofural
nitroxynil
solvent
Prior art date
Application number
HU844307A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT35955A (en
Inventor
Andrew Lewis
Maria R Clark
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of HUT35955A publication Critical patent/HUT35955A/hu
Publication of HU196307B publication Critical patent/HU196307B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HU844307A 1983-11-21 1984-11-20 Process for producing vermicides comprising levamisole-nitroxinil salt HU196307B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838331037A GB8331037D0 (en) 1983-11-21 1983-11-21 Compositions of matter

Publications (2)

Publication Number Publication Date
HUT35955A HUT35955A (en) 1985-08-28
HU196307B true HU196307B (en) 1988-11-28

Family

ID=10552109

Family Applications (1)

Application Number Title Priority Date Filing Date
HU844307A HU196307B (en) 1983-11-21 1984-11-20 Process for producing vermicides comprising levamisole-nitroxinil salt

Country Status (15)

Country Link
JP (1) JPS60123419A (fr)
AU (1) AU3564984A (fr)
BE (1) BE901095A (fr)
CA (1) CA1236402A (fr)
CH (1) CH662273A5 (fr)
DE (1) DE3442402A1 (fr)
DK (1) DK548884A (fr)
ES (1) ES8600933A1 (fr)
FR (1) FR2555047B1 (fr)
GB (2) GB8331037D0 (fr)
HU (1) HU196307B (fr)
IT (1) IT1177262B (fr)
NL (1) NL8403528A (fr)
NZ (1) NZ210247A (fr)
ZA (1) ZA849008B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0147883A3 (fr) * 1983-12-21 1986-12-30 Janssen Pharmaceutica N.V. Formulations "pour-on" anthelmintiques aqueuses et non-aggressives
AU5733986A (en) * 1985-05-13 1986-11-20 Syntex (U.S.A.) Inc. Anthelmintic compositions comprising a benzimidazole derivative and the fasciolicide rafoxanide
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
BRPI0506279B1 (pt) 2005-12-16 2018-01-09 Npa - Núcleo De Pesquisas Aplicadas Ltda Composição sinergística de antihelmínticos e endectocidas
CN100500648C (zh) * 2006-12-29 2009-06-17 浙江工业大学 一种硝碘酚腈的合成方法
BRPI0904365A2 (pt) * 2009-11-05 2011-11-16 Ouro Fino Participacoes E Empreendimentos S A associações farmacêuticas, composições farmacêuticas, medicamento e método para o tratamento de animais
WO2012089623A1 (fr) * 2010-12-27 2012-07-05 Intervet International B.V. Formulation d'isoxazoline d'application topique locale comprenant du glycofurol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
AU527154B2 (en) * 1978-12-15 1983-02-17 Pitman-Moore Australia Limited Composition and process
EP0052962B1 (fr) * 1980-11-20 1984-05-09 Beecham Group Plc Compositions pharmaceutiques contenant deux dérivés de bêta-lactame
NZ202422A (en) * 1981-11-25 1985-02-28 Ici Australia Ltd D, l-and l-2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazolium 4-cyano-2-iodo-6-nitrophenoxide and veterinary compositions

Also Published As

Publication number Publication date
FR2555047B1 (fr) 1987-04-17
DK548884D0 (da) 1984-11-19
AU3564984A (en) 1985-05-30
DK548884A (da) 1985-05-22
DE3442402A1 (de) 1985-05-30
ES537825A0 (es) 1985-10-16
ES8600933A1 (es) 1985-10-16
IT8423660A0 (it) 1984-11-20
GB2150024A (en) 1985-06-26
CA1236402A (fr) 1988-05-10
HUT35955A (en) 1985-08-28
JPS60123419A (ja) 1985-07-02
BE901095A (fr) 1985-05-20
GB2150024B (en) 1987-02-04
NZ210247A (en) 1988-01-08
CH662273A5 (fr) 1987-09-30
GB8331037D0 (en) 1983-12-29
GB8429264D0 (en) 1984-12-27
FR2555047A1 (fr) 1985-05-24
NL8403528A (nl) 1985-06-17
ZA849008B (en) 1985-07-31
IT8423660A1 (it) 1986-05-20
IT1177262B (it) 1987-08-26

Similar Documents

Publication Publication Date Title
DK1610613T3 (en) TOPICAL ANTHELMINTIC VETERINARY FORMULATIONS
EP0546018B1 (fr) Composition pharmaceutique de florfenicol
US9993485B2 (en) Highly concentrated stable meloxicam solutions for needleless injection
TWI522357B (zh) 用於治療癌症及其他疾病或病症之醫藥組合物
HU226778B1 (en) Injection and injection kit containing omeprazole and its analogs
AU2016367707B2 (en) Methods and compositions for treating gastric ulcers
EP1551390B1 (fr) Formulation comprenant des avermectines / milbemycines et levamisole dans un solvant pyrrolidone
HUP0203121A2 (hu) Szubsztituált benzimidazolokat tartalmazó gyógyszerkészítmény és alkalmazása
JP6736765B2 (ja) ベンダムスチン溶液製剤
HU196307B (en) Process for producing vermicides comprising levamisole-nitroxinil salt
AU2006322120B2 (en) Benzimidazole non-aqueous compositions
EP4230203A1 (fr) Microsuspension contre les parasites et procédé pour son obtention
US4618618A (en) Compounds and compositions
JP2022500350A (ja) 安定したアザシチジン含有医薬組成物の製造方法
AU2023202089B2 (en) Pemetrexed formulations
RU2618462C2 (ru) Способ и улучшенная фармацевтическая композиция для ускорения трансдермальной доставки ингибитора pde-5
NZ329247A (en) Anthelmintic compositions containing solubilised benzimidazoles such as oxfendazole and a carrier including a pyrrolidone
RU2660353C2 (ru) Способ и улучшенная фармацевтическая композиция для ускорения трансдермальной доставки ингибитора pde-5
NZ209027A (en) Preparation of sleeving for jointing or terminating electric cables
KR100354677B1 (ko) 염산암프롤륨과 술파퀴녹살린 나트륨을 함유하는 액상 동물용 의약품의 제조방법.
BRPI0505716B1 (pt) sal orgânico de levamisol, processo de preparação do mesmo, composição farmacêutica e seu uso no combate de helmintiases
BR112019016543B1 (pt) Composição líquida que contém pradofloxacina e seu uso
EP3178479A1 (fr) Composition injectable de ricobendazole
MX2014008172A (es) Composicion farmaceutica que comprende cloruro de isometamidium en solucion para el tratamiento de la tripanosomiasis en animales.